Hearing Loss Grading (WHO Classification)
Grades severity of hearing loss based on average hearing threshold (dB HL) per WHO classification. Guides audiological and surgical referral.
Score interpretation
WHO 2021: better-ear average below 20 dB HL.
→ No hearing loss by the better ear; check the worse ear for unilateral loss. Sudden-onset hearing loss: refer immediately (NICE NG98).
WHO 2021 grade: mild.
→ Treat reversible causes (wax, otitis media); audiology referral if hearing affects daily life. Sudden-onset hearing loss: refer immediately (NICE NG98).
WHO 2021 grade: moderate.
→ Audiology referral for assessment and hearing aid fitting; ENT if a conductive or asymmetric component. Sudden-onset hearing loss: refer immediately (NICE NG98).
WHO 2021 grade: moderately severe.
→ Audiology referral for hearing aids; ENT assessment. Sudden-onset hearing loss: refer immediately (NICE NG98).
WHO 2021 grade: severe.
→ Audiology and ENT referral; assess for cochlear implant candidacy. Sudden-onset hearing loss: refer immediately (NICE NG98).
WHO 2021 grade: profound.
→ Audiology and ENT referral; cochlear implant assessment. Sudden-onset hearing loss: refer immediately (NICE NG98).
WHO 2021 grade: complete or total.
→ Audiology and ENT referral; cochlear implant assessment. Sudden-onset hearing loss: refer immediately (NICE NG98).
Interpretation bands for the Hearing Loss Grade. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Prednisolone (Sudden Sensorineural Hearing Loss) · Corticosteroid (systemic — SSNHL treatment)
- Etonogestrel · Progestogen-only contraceptive implant
- Dexamethasone Intravitreal Implant 0.7 mg · Corticosteroid — Intravitreal Biodegradable Implant
- Fluocinolone Acetonide Intravitreal Implant 0.19 mg · Corticosteroid — Intravitreal Non-biodegradable Implant (36 months)
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.